Intelligent Bio Solutions Inc. (INBS) Stock Analysis

Company Overview

The market values Intelligent Bio Solutions Inc. (INBS) at $6.75M. It is classified in the Medical Devices industry, within the Healthcare sector. Headcount on file is 59.

INBS last closed at $2.23 on September 4, 2026. That is −$0.07 (−3.04%) against the previous close. Over the past 52 weeks the price has ranged from $1.52 to $24.90. The latest close sits 46.71% above that 52-week low.

Financial Health

Fiscal 2025 revenue came to $3.05M. Against the prior fiscal year total of $3.11M, that is a change of −1.90%. The same year closed with a net loss of $10.57M. Profit margin runs at −294.91%. That is 293.2 percentage points below the Medical Devices median of −1.69%. Earnings per share on a trailing basis come to −8.44.

Across the 4 fiscal years on file, revenue moves from $0.00 in 2022 to $3.05M in 2025. Of those 4 years, 0 report positive net income.

Valuation Assessment

The record shows negative trailing earnings, so no price-to-earnings ratio is published. The forward P/E on file is 6.37. Measured against sales, the shares trade at 1.6 times revenue. On price-to-sales that is 46.18% below the Medical Devices median of 2.98. The medians here are taken across 151 Medical Devices companies that report the metric.

The reported beta is 4.25. Daily returns over the trailing 5 years annualize to a volatility of 215.43%. The trailing one-year price return is −85.33%. Measured over 5 years, that is −80.64% a year compounded.

Growth & Income

The record shows no dividend for INBS.

Across the complete calendar years on file, 2025 returned −31.93% and 2023 returned −91.55%. Of the 5 complete calendar years on file, 0 finished higher. 2026 is still running; the price is −76.60% year to date.